Caricamento...
CRISPR Cas9 in Pancreatic Cancer Research
Pancreatic cancer is now becoming a common cause of cancer death with no significant change in patient survival over the last 10 years. The main treatment options for pancreatic cancer patients are surgery, radiation therapy and chemotherapy, but there is now considerable effort to develop new and e...
Salvato in:
| Pubblicato in: | Front Cell Dev Biol |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6813368/ https://ncbi.nlm.nih.gov/pubmed/31681770 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2019.00239 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|